Basket | Login


Call for abstracts

2021 Online

Abstact submisions are now Closed! All submitted abstracts have been evaluated, if you have not received your results please send us an Email.

Please note the abstract submission portal is still active for presentation of Keynote speakers and speakers of sponsored sessions only.

Alzheimer Europe called for abstracts for oral, quick oral and poster presentations on the following subjects:

Resilience and the COVID-19 pandemic:

  • Adapting day and community care
  • Learning the lessons of COVID-19 in nursing and residential care
  • Maintaining dementia as a public health priority
  • Mental health and dementia during the pandemic
  • New ways of diagnosing dementia and of recruiting and assessing research participants
  • Telecare and counselling

Societal and medical perspectives:

  • Arts and culture
  • Gender and sexuality
  • Intergenerational dementia initiatives
  • Rehabilitation in dementia
  • Risk factors and prevention
  • Young onset dementia

Alzheimer Europe is also calling for quick oral and poster presentations on the following subjects:

  • Awareness campaigns
  • Dementia-friendly initiatives
  • Initiatives supporting minority ethnic groups
  • Legal and ethical issues
  • Post-diagnostic support
  • Psychosocial interventions

Abstract Guidelines

Guidelines for writing abstracts

Please respect the following guidelines when writing your abstract:

  • Only abstracts submitted in English will be considered.
  • Abstracts need to be submitted via the online submission system. Abstracts submitted by e-mail, fax or post will be ignored.
  • Abstracts should be written in concise form and should not exceed one page (or 300 words).
  • Abstracts need to be submitted following the online template guidelines.
  • Please make sure to use a non-discriminatory language when referring to people with dementia. The terms “person with dementia” or “people with dementia “ should therefore be used rather than “victims”, “sufferers”, the “demented” or “dementing” or other stigmatising language.
  • As AE Conferences are open to a lay audience, presentations on licensed medicines, whether promotional in nature or not, will not be accepted. The use of trade marked names is similarly not allowed.
  • Abstracts should be clearly linked to one of the topics of the call for abstracts. You will be asked to choose a specific topic when submitting your abstract.

Guidelines for submitting abstracts

  • Alzheimer Europe will accept submission of abstracts for oral, quick oral or poster presentations. Please indicate on the form, if you submit your abstract for oral, quick oral or poster presentation only.
  • Please note that oral presentations will be for 10-12 minutes followed by 3 to 5 minutes of questions. You will have the choice of pre-recording your presentation or presenting live. If pre-recording your presentation, please be available during your session for live questions.
  • Quick oral presentations will need to be pre-recorded and shall not exceed 5 minutes.
  • Posters and presentation recordings will be made available on demand until the event platform is closed on 31 March 2022.
  • Alzheimer Europe may use screenshots from presenters to share via social media, newsletter and magazine.
  • All abstracts must be submitted by 30 June at the latest.
  • You will receive an e-mail notification after submitting your abstract. If you have not received an e-mail notification after submitting your abstract, please contact the Alzheimer Europe secretariat.

Evaluation of abstracts

  • All abstracts will be evaluated by the Programme Committee.
  • For each topic, a minimum of 3 or 4 members of the Programme Committee will rate each abstract which will have been anonymised prior to evaluation.
  • For abstracts submitted for oral presentations, the following procedure will apply:
  • The five highest rated abstracts for each topic will be selected as oral presentations for inclusion in the final programme.
  • Only one abstract per author will be accepted for inclusion as an oral presentation. If more than one abstract qualifies, only the highest rated abstract will be included in the final programme. Additional abstracts by the same author may be accepted as quick oral or poster presentations.
  • Abstracts that have not been accepted for oral presentation can be selected for quick oral or poster presentations as long as they reach the required threshold average mark.
  • Abstracts that have not reached the required average mark will be rejected.
  • For abstracts submitted for quick oral and poster presentations, the following procedure will apply:
  • Abstracts that have reached the required threshold average mark will be accepted.
  • All other abstracts will be rejected.

Acceptance of abstracts

  • All authors will be informed about the decision of the Programme Committee by 31 July 2021.
  • If accepted, only minor changes to the submitted abstract will be permitted. It is the author’s responsibility to ensure that abstracts are correct in terms of accuracy of contents, spelling and grammar.
  • All presenters need to register for the conference by the early bird registration deadline of 15 September 2021.



Last Updated: Thursday 05 August 2021


  • Acknowledgements

    The 31st AE Conference received funding under an operating grant from the European Union’s Health Programme (2014-2020). Alzheimer Europe gratefully acknowledges the support of all conference sponsors.
  • European Union
  • Roche